Latest news
India Approved Its First Dengue Vaccine. Access Is Still Unwritten.
India has approved QDENGA, creating the country’s first licensed dengue-vaccine option. The scientific milestone is real. The public-health result will depend on targeting, procurement, price and two-dose delivery in the districts carrying the greatest risk.
Medicare’s GLP-1 Bridge Turns Obesity Coverage Into a Public-Payer Experiment
WHO Makes Obesity Treatment a Global Access Test
Cyberbullying Becomes a Youth Mental Health Policy Target
Alzheimer’s Agitation Gets a New Drug, But Care Pathways Still Lag
Rare Epilepsy Moves Toward Treating the Cause
Huntington Gene Therapy Hits the Evidence Wall
Rare Disease Policy Moves Into the Individualised Therapy Era
Digital Mental Health Still Has an Evidence Problem
Alzheimer’s Access Now Starts With Genotyping and MRI Capacity
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.